Advertisement Symplmed, PuraCap Pharmaceutical team up to distribute new EpiCeram-L Lip Care - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Symplmed, PuraCap Pharmaceutical team up to distribute new EpiCeram-L Lip Care

Symplmed has entered into an agreement with PuraCap Pharmaceutical to distribute a new product, EpiCeram-L Lip Care, through Symplmed’s patented DyrctAxess technology.

The program is designed to provide physicians with easy access to PuraCap’s growing portfolio of dermatology products.

From PuraCap Pharmaceutical, the makers of EpiCeram Controlled Release Skin Barrier Emulsion, comes a unique lip care formulation with an exclusive delivery system developed specifically for severely chapped, dry, or cracked lips.

EpiCeram-L Lip Care uses patented MultiSal technology to deliver 3 essential lipids – ceramides, free fatty acids and cholesterol in an all-natural, fragrance-free, and color-free formulation. EpiCeram-L Lip Care is available exclusively through prescribing healthcare professionals.

Symplmed Pharmaceuticals president and CEO Erik Emerson said: "Partnering with PuraCap to accelerate their product distribution through our DyrctAxess platform is continued validation of our technology.

"PuraCap has a strong, growing portfolio of dermatology products which we’re excited to offer in their own customized execution of DyrctAxess."

"Symplmed demonstrated a strong understanding and history of success in the execution of direct ordering and fulfillment," said Elise Klein, Vice President and General Manager of PuraCap’s Branded Rx division.

"We look forward to working with Symplmed to continue to meet the needs of our physicians and patients through the introduction of EpiCeram-L Lip Care."

PuraCap is the third execution of Symplmed’s DyrctAxess technology which is designed to streamline the product fulfillment process.